Virtually all of the Gr1+ cells (mostly neutrophils) and the Gr1+CD11b+ double positive cells (neutrophils and macrophages lineage) from bone marrow and peripheral blood of tumor-bearing mice were depleted upon treatment with anti-Gr1 antibody (Fig. 6A). This evidence concerns the gene ITGAM and neoplasm.